Our team
We are supported by a board of directors comprising some of the leading lights of the European healthcare ecosystem and advised by highly respected expert clinicians working in the field of interventional radiology and nuclear medicine from Europe and the US.
Leadership team
Alexis Peyroles MBA
Chief Executive Officer (CEO)>25y Biotech and Pharma experience
Chairman Inside Tx & OWL Life Sciences
Former COO & CEO OSE Immunotherapeutics
Former General Manager LatAm at Guerbet
Former Group Financial Controller at Sanofi

Pietro Bubba Bello
Head of Manufacturing & OperationsFormer Site Head, Director of Operations, and Plant Director of Operations and HSE Country Manager at Novartis
Former Site Head and Qualified Person and Head of Quality Control at Advanced Accelerator Applications

Gaia Bisaccioni
Head of RA/QAFormer Quality Site Head at Advanced Accelerator Applications
Former Quality Site Head & Deputy Qualified Person at Advanced Accelerator Applications

Dr. Carol Hegarty
Clinical Operations ManagerOver 20 years of experience in Clinical Operations within the medical device sector.
Previously held responsibility for the operational oversight of global health initiatives, ensuring the successful delivery of strategic clinical data to support projects across drug delivery, wound management, and fast-moving consumer goods, with a focus on aligning clinical outcomes with commercial and regulatory objectives.

Board of directors
Mike Cogswell
Chairman34 years of proven expertise in international healthcare leadership
Chairman of DermaCure RT & EbaMed SA
CEO & President of MagneTx Oncology Solutions Inc.
Managing Director of Mureva Phototherapy Inc.
Former SVP global sales ViewRay Inc., Mevion Medical Systems Inc. & Elekta Inc.

Alexis Peyroles MBA
Chief Executive Officer (CEO)>25y Biotech and Pharma experience
Chairman Inside Tx & OWL Life Sciences
Former COO & CEO OSE Immunotherapeutics
Former General Manager LatAm at Guerbet
Former Group Financial Controller at Sanofi

Dr. Michel Therin DVM, PhD
Independent Non-Executive DirectorPresident of MT2 Consulting
Former President Advanced Therapies at Siemens Healthineers
Former Global Vice President at Medtronic Minimally Invasive Therapies Group

Gerry Hogue NACD.DC
Independent DirectorFormer Chairman & CEO VieCure Medical Inc.
Former NED Point Biopharma, Momentum Healthware & Precision Cancer Technologies
Former SVP & General Manager Elekta Inc.
Former Chairman & CDEO OpTx Corporation

Liliana Nordbakk
Investor Director (Neva)Partner, Neva SGR, Life Sciences
Board Observer, Tr1X Bio Inc.
Former Chair, NorCom IT GmbH
Co-founder, Kamau Therapeutics Inc.
Former Chair, Life Science Group, Band of Angels

Francesco Berri
Investor Director (Liftt & FinPosillipo)Head of M&A & Business Development at LIFTT
Former VP at Lazard
Former Corporate M&A at GE

Marco Venturelli
Investor Director (Origine)International executive with 30 years in Novartis
Medtech Venture Partner in Origine Sgr
Chairman of the BoD in Checkmab Srl
Board member in Newronika SpA and Anaconda Biomed
Life sciences & well-being Ambassador at MIND Milan Innovation District

Clinical advisory board
Prof. Jafar Golzarian MD
Interventional RadiologistChairman of the advisory board
University of Minnesota Divisional Director IR & Vascular Imaging
Co-founder & President of GEST annual symposium

Prof. Govindarajan Narayanan MD
Interventional RadiologistChief of Interventional Oncology for the Miami Cancer Institute
Course Director of the SPECTRUM IR oncology conference

Prof. Marco Maccauro MD
Nuclear PhysicianAssociate Professor, of Nuclear Medicine at University of Milan.
Associate Director of Nuclear Department at National Cancer Institute Milan.

Prof. Flavio Rocha MD
Hepatobiliary SurgeonHedinger Professor of Surgery.
Division Head of Surgical Oncology.
Physician-in-Chief, Knight Cancer Institute.
Oregon Health and Science University.

Prof. Peter J. Hosein
Professor of Clinical MedicineDepartment of Medicine, Division of Medical Oncology, University of Miami Miller School of Medicine
Co-Leader Gastrointestinal Cancers Site Disease Group, Sylvester Comprehensive Cancer Center
Associate Director of Clinical Research, Sylvester Pancreatic Cancer Research Institute
Member, Scientific and Medical Advisory Board, Pancreatic Cancer Action Network
Member, National Cancer Institute Pancreas Task Force





